Feature Briefing Avastin and Lucentis: a guide through the legal maze BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h1377 (Published 01 April 2015) Cite this as: BMJ 2015;350:h1377 Article Related content Metrics Responses Peer review Related articles Feature Why have UK doctors been deterred from prescribing Avastin? Published: 01 April 2015; BMJ 350 doi:10.1136/bmj.h1654 News Minister rules out use of Avastin over Lucentis for wet AMD Published: 16 April 2015; BMJ 350 doi:10.1136/bmj.h2050 See more Glad to be gay in India BMJ September 11, 2018, 362 k3885; DOI: https://doi.org/10.1136/bmj.k3885 Sixty seconds on . . . Mind the Rota Gap BMJ January 31, 2017, 353 i2212; DOI: https://doi.org/10.1136/bmj.i2212 Academies urge UK government to invest in research after Brexit vote BMJ November 17, 2016, 355 i6179; DOI: https://doi.org/10.1136/bmj.i6179 We need more humanity as well as better evidence BMJ November 03, 2016, 355 i5907; DOI: https://doi.org/10.1136/bmj.i5907 GP leader attacks CCGs for £30m underspend BMJ October 06, 2016, 355 i5443; DOI: https://doi.org/10.1136/bmj.i5443 Cited by... Why have UK doctors been deterred from prescribing Avastin?Fulltext PDF